Home›Trial›NCT07422298
🔬NCT07422298Phase 1RECRUITING

A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

Study Summary

The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.

Conditions
Healthy Volunteers
Interventions / Drugs
BMS-986278PlaceboMoxifloxacin
View on ClinicalTrials.gov ↗
Sponsor
BMY
Bristol-Myers Squibb
Oncology
F35/100
Study Details
Enrollment32 participants
Primary Completion—
Lead SponsorBristol-Myers Squibb
Data Retrieved2026-04-11 04:08:14.746334+00:00
Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.